Finland | A new research initiative is exploring how 3D printing technology can fabricate custom-tailored medications customized to individual user needs. The ongoing 3D-CURE project aims to pioneer a data-driven framework to industrialize personalized medicine, tailoring precise doses, delivery formats, solubility levels, and flavor profiles directly at local pharmacies according to doctor prescriptions.While exploratory 3D pharmaceutical printing has been trialed in Finland for vascular and non-steroidal anti-inflammatory drugs (NSAIDs), the technology remains largely inside the research and development phase. Widespread implementation faces several manufacturing hurdles, including the cost-effectiveness of mass production over custom fabrication, strict medical regulations, and the technical complexity of encapsulating distinct therapeutic molecules safely inside printing matrices.To solve these issues, researchers at Turku UAS are assessing drug implant solubility by submerging carrier materials in 37°C water to simulate internal human body temperatures. Additionally, the university is deploying mathematical modeling and “digital twins”—virtual counterparts of real physical components—to optimize drug release rates. The 3D-CURE consortium brings together four research organizations and prominent pharmaceutical partners to systematically test innovative bio-materials.
Source: Turku University of Applied Sciences
#WordMain #StudentNewsPortal #Europe #studentnews
About the Author
